Upasana is making waves in the business world as one of the youngest and most dynamic independent directors in India of a publicly listed company
Mumbai, 2nd March 2023: With changing times and emerging technologies, it is imperative that listed healthcare companies have a diverse and dynamic board of directors to guide them through the ever-changing landscape. One critical element of a diverse board is the inclusion of young independent directors who bring fresh perspectives and insights that are invaluable to the decision-making process. Young independent directors are more likely to have a longer-term view of the business and can help companies plan efficiently for the future.
Zydus Lifesciences Limited, one of India’s leading multinational pharmaceutical companies with a market capitalisation of INR 476 billion, has announced the appointment of Upasana Kamineni Konidela as an Independent Director for the first term of five consecutive years with effect from November 29, 2022.
Through meticulous analysis of Upasana’s skill set, knowledge and experience in Healthcare and Philanthropy, the Nomination and Remuneration Committee (NRC), recommended her appointment for the efficient functioning of the company with her expertise particularly in the areas of, Human Resources, Corporate Social Responsibility and Information Technology.
Currently, Upasana is making waves in the business world as one of the youngest and most dynamic independent directors in India of a publicly listed company. She strongly believes in building sustainable businesses deeply rooted in social welfare that create a long-term, profound impact.
Commenting on her appointment on the Board, Dr. Sharvil Patel, MD of Zydus Lifesciences Limited told: “With a proven track record in the healthcare industry, a strong background in driving business growth and a passion for innovation, Ms. Upasana Kamineni Konidela brings a diverse set of skills, fresh perspectives, and valuable insights. We look forward to her contributions and welcome new ideas to the Board.”
Commenting on her appointment, Upasana Konidela said, “I am looking forward to my association with an inclusive, customer-centric, dynamic global organization. I’m optimistic that by pulling the right strategic levers, Zydus Lifesciences Limited will be able to continue to make meaningful differences in the life of consumers through quality healthcare solutions globally. As I take up this challenging yet exciting new role, we will carry on, in tune with the company’s vision of pursuing cutting-edge science for the benefit of society.”
Zydus Lifesciences Limited has a legacy of over 70 years in healthcare and is racing ahead and exploring a new decade of opportunities. There are 23000 people across the world working on an overarching purpose to empower people with the freedom to live healthier and more fulfilled lives. As a global life sciences company, the vision is to transform lives through path-breaking discoveries. The group’s mission is to unlock new possibilities in life sciences through quality healthcare solutions that impact lives. As a future-focused organisation, the group is racing ahead in its journey of growth and innovation will be one of the key drivers of success. Zydus Lifesciences Limited has been pioneering several first-in-India and first-in-the-world products that bridge unmet healthcare needs and have been of great help to patients.
